Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide once weekly plus lifestyle vs placebo plus lifestyle in adolescents with obesity
2015-001628-45Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Exenatide 2 mg once weekly + lifestyle intervention with Placebo once weekly + lifestyle intervention (2 arms). Primary endpoint: BMI SDS change from baseline to 6 months. Started Jul 2015; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on 2015-001628-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001628-45.